Based on supporting results, we suggest that inflammation in the COVID-19 airway may be initiated by inhibition of CFTR signaling by SARS-CoV-2 spike protein, thus inducing a cystic fibrosis-like proinflammatory clinical phenotype. The gene discussed is CFTR; the disease is cystic fibrosis.